flecainide has been researched along with cifenline in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (12.12) | 18.7374 |
| 1990's | 17 (51.52) | 18.2507 |
| 2000's | 11 (33.33) | 29.6817 |
| 2010's | 1 (3.03) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Arita, M; Kiyosue, T; Sato, T; Wu, B | 1 |
| Kato, R; Koide, M; Miyahara, T; Sotobata, I; Toyama, J; Ukai, M; Yasui, S; Yokota, M | 1 |
| Vaughan Williams, EM | 1 |
| Kühlkamp, V; Risler, T; Schmid, F; Seipel, L | 1 |
| Aupetit, JF; Faucon, G; Gerentes-Chassagne, I; Larbre, JP; Loufoua-Moundanga, J; Timour, Q | 1 |
| Aupetit, JF; Faucon, G; Gerentes-Chassagne, I; Kioueh, I; Loufoua-Moundanga, J; Timour, Q | 1 |
| Bajolet, A; Chabert, JP; Chapoutot, L; Ehrhard, V; Laudinat, JM; Metivet, F; Metz, D; Pollet, E; Taupin, JM | 1 |
| Somberg, J | 1 |
| Baudouy, M; Camous, JP; Gibelin, P; Ichai, C; Meyer, P; Morand, P; Varenne, A | 1 |
| Touboul, P | 1 |
| Atallah, G; Kirkorian, G; Moleur, P; Touboul, P | 1 |
| Babuty, D; D'Hautefeuille, B; Mycinsky, C; Peraudeau, P; Pruvost, P; Scheck, F | 1 |
| Lüderitz, B; Manz, M | 1 |
| Aupetit, JF; Faucon, G; Kioueh, I; Larbre, JP; Lopez, M; Loufoua-Moundanga, J; Timour, Q | 1 |
| Aouate, P; Benassar, A; Fontaine, G; Frank, R; Jacquemin, M; Laborde, JP; Tageddine, R; Tonet, J; Turlure, A | 1 |
| Arita, M; Kiyosue, T; Sato, T; Wang, DW | 1 |
| Babuty, D; Brembilla-Perrot, B; Breuillac, JC; Fauchier, JP; Funck, F; Garnier, LF; Maison-Blanche, P; Medvedowsky, JL; Peraudeau, P; Rouesnel, P; Scheck, F | 1 |
| Mahmood, I | 1 |
| Beurrier, D; Brembilla-Perrot, B; Danchin, N; Houplon, P; Jacquemin, L; Louis, P; Terrier de la Chaise, A | 1 |
| Adamantidis, M; Cardinal, R; Delfaut, P; Dupuis, B; Kacet, S; Klug, D; Lacroix, D | 1 |
| Allessie, MA; Dorland, R; Wijffels, MC | 1 |
| Allessie, MA; Dorland, R; Mast, F; Wijffels, MC | 1 |
| Caron, J; Defebvre, L; Destée, A; Devos, D | 1 |
| Imai, H; Matoba, Y; Nakagawa, M; Shiraishi, H; Shirayama, T; Yoshida, S | 1 |
| Abo el Makarem, Y; Brembilla-Perrot, B; Claudon, O; Courtelour, JM; Houriez, P; Makarem, E; Suty-Selton, C; Vancon, AC; Yassine, M | 1 |
| Allessie, MA; Ausma, J; Blaauw, Y; Duytschaever, M; Eijsbouts, S; Schotten, U | 1 |
| Anderson, ME | 1 |
| Furukawa, T; Hachiya, H; Higuchi, K; Hirao, K; Isobe, M; Kawabata, M; Okada, H; Sasaki, T | 1 |
| Aoyama, H; Enomoto, M; Hirayama, A; Imai, S; Kushiro, T; Saito, F; Takase, H; Yagi, H; Yamaji, S; Yokoyama, K | 1 |
6 review(s) available for flecainide and cifenline
| Article | Year |
|---|---|
Classifying antiarrhythmic actions: by facts or speculation.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Heart; Humans; Imidazoles | 1992 |
[Comparative study of cibenzoline and flecainide administered via an intravenous route in reducing auricular arrhythmia].
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Flecainide; Humans; Imidazoles; Injections, Intravenous; Injections, Jet; Male; Middle Aged | 1990 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
[New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Electrophysiology; Encainide; Flecainide; Hemodynamics; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Sotalol; Tocainide | 1982 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil | 1993 |
[Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Heart Rate; Humans; Imidazoles; Male; Middle Aged; Propafenone; Tachycardia, Supraventricular | 1995 |
4 trial(s) available for flecainide and cifenline
| Article | Year |
|---|---|
Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Female; Flecainide; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Random Allocation; Recurrence | 1991 |
Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Drug Tolerance; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Flecainide; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Physical Examination; Recurrence | 1995 |
[Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Flecainide; Humans; Imidazoles; Male; Middle Aged; Recurrence | 1997 |
Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Natriuretic Factor; Bepridil; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Follow-Up Studies; Humans; Imidazoles; Lidocaine; Male; Middle Aged; Natriuretic Peptide, Brain; Sinoatrial Node; Treatment Outcome | 2008 |
23 other study(ies) available for flecainide and cifenline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
Topics: 2,4-Dinitrophenol; Action Potentials; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Dinitrophenols; Disopyramide; Flecainide; Glyburide; Guinea Pigs; Heart Ventricles; Imidazoles; Lidocaine; Mexiletine; Myocardium; Piperidines; Potassium; Procainamide; Pyridines | 1992 |
[Pharmacokinetics and pharmacodynamics of class I antiarrhythmic agents after a single oral administration].
Topics: Administration, Oral; Anti-Arrhythmia Agents; Aprindine; Flecainide; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone | 1992 |
[Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Disease; Disease Models, Animal; Flecainide; Imidazoles; Injections, Intravenous; Propafenone; Swine | 1991 |
Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Blood Pressure; Coronary Disease; Coronary Vessels; Female; Flecainide; Heart Conduction System; Heart Rate; Imidazoles; Male; Propafenone; Swine; Ventricular Fibrillation | 1991 |
[Treatment of poisoning caused by new anti-arrhythmia agents (cibenzoline, flecainide and propafenone)].
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Flecainide; Humans; Imidazoles; Lactates; Lactic Acid; Male; Middle Aged; Propafenone | 1987 |
[New class I anti-arrhythmia agents].
Topics: Anti-Arrhythmia Agents; Bepridil; Flecainide; Humans; Imidazoles; Kinetics; Propafenone; Pyrrolidines | 1986 |
Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Electrocardiography; Female; Flecainide; Heart Conduction System; Heart Rate; Imidazoles; Male; Myocardial Ischemia; Propafenone; Swine | 1993 |
Comparison of the effects of class I anti-arrhythmic drugs, cibenzoline, mexiletine and flecainide, on the delayed rectifier K+ current of guinea-pig ventricular myocytes.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Flecainide; Guinea Pigs; Imidazoles; Ion Transport; Mexiletine; Patch-Clamp Techniques; Potassium; Ventricular Function | 1996 |
Prediction of absolute bioavailability for drugs using oral and renal clearance following a single oral dose: a critical view.
Topics: Acebutolol; Administration, Oral; Adult; Aged; Amiloride; Anti-Arrhythmia Agents; Anti-Infective Agents; Area Under Curve; Atenolol; Biological Availability; Diuretics; Enoxacin; Flecainide; Histamine H2 Antagonists; Humans; Imidazoles; Kidney; Middle Aged; Ranitidine; Renal Insufficiency; Tiopronin | 1997 |
[Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Disopyramide; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Imidazoles; Male; Middle Aged; Predictive Value of Tests; Propafenone; Quinidine; Risk Factors | 1997 |
Differential effects of quinidine, flecainide, and cibenzoline on anisotropic conduction in the isolated porcine heart.
Topics: Action Potentials; Animals; Anisotropy; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiac Pacing, Artificial; Female; Flecainide; Heart; Heart Conduction System; Imidazoles; In Vitro Techniques; Pericardium; Potassium Channel Blockers; Quinidine; Swine | 1998 |
Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Disease Models, Animal; Electrocardiography; Flecainide; Follow-Up Studies; Goats; Heart Conduction System; Imidazoles; Injections, Intravenous; Quinidine; Secondary Prevention; Sotalol; Treatment Outcome | 1999 |
Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Flecainide; Goats; Heart Conduction System; Imidazoles; Quinidine; Sotalol | 2000 |
Choreic movements induced by cibenzoline: an Ic class antiarrhythmic effect?
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chorea; Dopamine Antagonists; Dyskinesia, Drug-Induced; Dystonia; Female; Flecainide; Humans; Imidazoles; Ion Channels; Pacemaker, Artificial; Potassium; Remission Induction; Sulpiride | 2000 |
Atrial fibrillation threshold predicted long-term efficacy of pharmacological treatment of patients without structural heart disease.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Disopyramide; Electrophysiologic Techniques, Cardiac; Female; Flecainide; Humans; Imidazoles; Lidocaine; Male; Middle Aged; Treatment Outcome | 2002 |
[Can the supraventricular proarrhythmic effects of class 1C antiarrhythmic drugs be prevented with the association of beta blockers?].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Flutter; Female; Flecainide; Humans; Imidazoles; Male; Middle Aged | 2000 |
Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Electrocardiography; Female; Flecainide; Goats; Heart Conduction System; Imidazoles; Time Factors | 2006 |
Too little, too late: chasing atrial fibrillation with sodium channel antagonists.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Flecainide; Heart Conduction System; Humans; Imidazoles; Potassium Channel Blockers; Sodium Channel Blockers; Time Factors | 2006 |
Clinical and electrophysiological characteristics of patients having atrial flutter with 1:1 atrioventricular conduction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Case-Control Studies; Catheter Ablation; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Flecainide; Heart Atria; Heart Conduction System; Heart Ventricles; Humans; Imidazoles; Lidocaine; Male; Middle Aged; Retrospective Studies; Risk Factors | 2008 |